Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Kim

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
JACC. Case Reports|March 20, 2026
Advanced Heart Failure in Friedreich's Ataxia: A Story of Challenges, Opportunities, and HopeSatoshi Miyashita, Anthony Zaki, Kaitlin Schlabach, et al.
Cureus|September 2, 2025
Correction: Integrating Gait Analysis Systems in Clinical Rehabilitation Settings for Individuals With Lower Limb Amputation: A Narrative ReviewXiaoning Yuan, Tawnee Sparling, David Carlisle, et al.
Cardiovascular Diabetology|December 25, 2015
Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trialMichael Roden, Ludwig Merker, Anita Vedel Christiansen, et al.
Cureus|September 2, 2025
Integrating Gait Analysis Systems in Clinical Rehabilitation Settings for Individuals With Lower Limb Amputation: A Narrative ReviewXiaoning Yuan, Tawnee Sparling, David Carlisle, et al.
Diabetes Research and Clinical Practice|September 2, 2015
Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetesHans-Ulrich Haering, Ludwig Merker, Anita Vedel Christiansen, et al.
Clinical Therapeutics|July 4, 2015
Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes MellitusChristopher S Kovacs, Veeraswamy Seshiah, Ludwig Merker, et al.
Frontiers in Cellular and Infection Microbiology|July 22, 2025
Skin microbiome-biophysical association: a first integrative approach to classifying Korean skin types and aging groupsSeyoung Mun, HyungWoo Jo, Young Mok Heo, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
JACC. Case Reports|March 20, 2026
Advanced Heart Failure in Friedreich's Ataxia: A Story of Challenges, Opportunities, and HopeSatoshi Miyashita, Anthony Zaki, Kaitlin Schlabach, et al.
Cureus|September 2, 2025
Correction: Integrating Gait Analysis Systems in Clinical Rehabilitation Settings for Individuals With Lower Limb Amputation: A Narrative ReviewXiaoning Yuan, Tawnee Sparling, David Carlisle, et al.
Cardiovascular Diabetology|December 25, 2015
Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trialMichael Roden, Ludwig Merker, Anita Vedel Christiansen, et al.
Cureus|September 2, 2025
Integrating Gait Analysis Systems in Clinical Rehabilitation Settings for Individuals With Lower Limb Amputation: A Narrative ReviewXiaoning Yuan, Tawnee Sparling, David Carlisle, et al.
Diabetes Research and Clinical Practice|September 2, 2015
Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetesHans-Ulrich Haering, Ludwig Merker, Anita Vedel Christiansen, et al.
Clinical Therapeutics|July 4, 2015
Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes MellitusChristopher S Kovacs, Veeraswamy Seshiah, Ludwig Merker, et al.
Frontiers in Cellular and Infection Microbiology|July 22, 2025
Skin microbiome-biophysical association: a first integrative approach to classifying Korean skin types and aging groupsSeyoung Mun, HyungWoo Jo, Young Mok Heo, et al.
Pageof 2